News

The technology developed at the University of Michigan continuously uses data from a single electrocardiogram lead.

Recruitment is now complete with 100 patients planned per protocol in the fenestrated endovascular aortic aneurysm repair (FEVAR) study.

There was currently no specific risk algorithm for this region, so this development will allow greater accuracy in identifying people at high risk of cardiovascular disease in clinical practice.

• The system will collect information from various medical teams and send it via secure, low-latency, high-bandwidth mobile communications to the specialist technician, who will then be able to visualise and analyse the physician's assistance...

Neutrophils promote irregularities while macrophages protect against them

Dr. Robert Drennan, electrophysiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Abbott Aveir™ VR Leadless Pacemaker to treat abnormal heart rhythm. The procedure took place in the catheterization...

Among people who received endovascular therapy to mechanically remove a clot in their large brain artery, those who had a rare genetic variant found primarily in people of East Asian descent (Japanese, Chinese and Korean) were more likely to...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke.

VDI’s MobiusHD device is designed to provide interventionalists with a minimally-invasive transcatheter approach to help treat patients suffering from continued heart failure problems despite pharmaceutical therapy.

Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection Fraction